-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cyteir Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
- Cyteir Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $599K, a 49.8% decline year-over-year.
- Cyteir Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $3.29M, a 33.6% decline year-over-year.
- Cyteir Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.68M, a 35.1% increase from 2021.
- Cyteir Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.47M, a 642% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)